LGI1 Encephalitis Maintenance — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Rituximab
LGI1 encephalitis responds well to first-line immunotherapy (corticosteroids). FBDS often respond dramatically within days. However, relapse rates are high (20-30%) on steroid tapering. Rituximab is increasingly used as maintenance to allow steroid weaning and prevent relapse. Long-term immunosuppression (12-24 months) is typically needed.
Reference: Lancet Neurol 2024 Autoimmune Encephalitis; eTG Neurology 2024